Act Capital Management, LLC Oncocyte Corp Transaction History

Act Capital Management, LLC

  • $72.5 Million
  • Q3 2022

A detailed history of Act Capital Management, LLC transactions in Oncocyte Corp stock. As of the latest transaction made, Act Capital Management, LLC holds 330,000 shares of OCX stock, worth $973,500. This represents 0.33% of its overall portfolio holdings.

Number of Shares
330,000
Previous 330,000 -0.0%
Holding current value
$973,500
Previous $297,000 18.86%
% of portfolio
0.33%
Previous 0.42%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
BUY
$3.77 - $6.0 $1.24 Million - $1.98 Million
330,000 New
330,000 $1.9 Million

Others Institutions Holding OCX

# of Institutions
4
Shares Held
1.16M
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $350M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email